Atopic dermatitis

Journal of Pharmacy Practice

Volumn 23, Issue 2, 2010, Pages 110-116

  Ghazvini, Patty ^a   Pagan, Luis C ^a   Rutledge, Toby K ^a   Goodman Jr , H Stewart ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Atopic dermatitis; Inflammatory skin disease; Topical calcineurin inhibitors; Topical corticosteroids; UV phototherapy

Indexed keywords

BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CHAMOMILE; EMOLLIENT AGENT; FLUTICASONE PROPIONATE; GLYCYRRHIZA EXTRACT; HYDROCORTISONE; KAMILLOSAN; PIMECROLIMUS; PLACEBO; SHIUNKO; TACROLIMUS; UNCLASSIFIED DRUG; ZEMAPHYTE;

ATOPIC DERMATITIS; BEHAVIOR MODIFICATION; DIET RESTRICTION; DIFFERENTIAL DIAGNOSIS; ERYTHEMA; GLYCYRRHIZA; HUMAN; IMMUNOPATHOGENESIS; PHOTOTHERAPY; PREVALENCE; PSYCHOTHERAPY; REVIEW; SEX RATIO; SKIN BURNING SENSATION; SKIN PRURITUS; STRESS MANAGEMENT;

EID: 77953673949     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190009360634     Document Type: Review

References (49)

1. Levy RM, Gelfand JM, Yan AC The epidemiology of atopic dermatitis. Clin Dermatol. 2003 ; 21 (2). 109-115.
2. Beiber T. Atopic dermatitis. N Engl J Med. 2008 ; 358 (14). 1483-1494.
3. Hanifen JM, Rajka G. Diagnostic feature of atopic dermatitis. Acta Derm Venereol. 1980 ; 92 :(suppl): 44-47.
4. Kang K., Stevens S. Pathophysiology of atopic dermatitis. Clin Dermatol. 2003 ; 21 (2). 116-121.
5. Kang KF, Tian RM Atopic dermatitis. An evaluation of clinical and laboratory findings. Int J Dermatol. 1987 ; 26 (1). 27-32.
6. Lipozenencic J., Wolf R. Atopic dermatitis: an update and review of the literature. Dermatol Clin. 2007 ; 25 (4). 605-612.
7. Rosen F., Geha R. Case Studies in Immunology. New York, NY: Garland Publishing ; 2004.
8. Akdis CA, Akdis M., Bieber T., et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology; Clinical Immunology, Asthma and Immunology/ PRACTICALL Consensus Report. Allergy. 2006 ; 61 (1). 969-987. (Pubitemid 44024897)
9. Ong PY, Boguniewics M. Atopic dermatitis. Prim Care. 2008 ; 35 (1). 105-117.
10. Williams HC: Clinical practice. Atopic dermatitis. N Engl J Med. 2005 ; 352 (22). 2314-2324.
11. Wessler I., Reinheimer T., Kilbinger H., et al. Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis. Life Sci. 2003 ; 72 (18-19). 2169-2172.
12. Sampson HA Update on food allergy. J Allergy Clin Immunol. 2004 ; 113 (5). 805-819.
13. Williams HC Diagnostic criteria for atopic dermatitis (letter). Lancet. 1996 ; 348 (1). 1391-1392.
14. Williams HC On the definition and epidemiology of atopic dermatitis. Dermatol Clin. 1995 ; 13 (3). 649-657.
15. Williams HC, Forsdyke H., Boodoo G., et al. A protocol for recording the sign of flexural dermatitis in children. Br J Dermatol. 1995 ; 133 (6). 941-949.
16. Halbert AR The practical management of atopic dermatitis in children. Pediatr Ann. 1996 ; 25 (2). 72-78.
17. Bindslev-Jensen C., Ballmer-Weber B., Bengtsson U., et al. Standardization of food challenges in patients with immediate reactions to foods-position paper from the European Academy of Allergology and Clinical Immunology. Allergy. 2004 ; 59 (7). 690-697.
18. Scalabrin D., Bavbek S., Perzanowski M., et al. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol. 1999 ; 104 (6). 1273-1279.
19. Werfel T., Breuer K. Role of food allergy in atopic dermatitis. Curr Opin Allergy Clin Immunol. 2004 ; 4 (5). 379-385.
20. Darsow U., Laifaoui J., Kerschenlohr K., et al. The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy. 2004 ; 59 (12). 1318-1325.
21. Leung DY Infection in atopic dermatitis. Curr Opin Pediatr. 2003 ; 15 (4). 399-404.
22. Howell M., Wollenberg A., Gallo R., et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol. 2006 ; 117 (4). 836-841.
23. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines for atopic dermatitis. J Am Acad Dermatol. 2004 ; 50 (3). 391-404.
24. Staughton R. Psychologic approach to atopic skin disease. J Am Acad Dermatol. 2001 ; 45 (1 suppl). S53 - S54.
25. Ehlers A., Stangier U., Gieler U. Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol. 1995 ; 63 (4). 624-635.
26. Sloper KS, Wadsworth J., Brostoff J. Children with atopic eczema. I: Clinical response to food elimination and subsequent double-blind food challenge. Q J Med. 1991 ; 80 (292). 677-693.
27. Williams HC Atopic dermatitis. N Engl J Med. 2005 ; 352 (22). 2314-2324.
28. Krutmann J., Diepgen TL, Luger TA, et al. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol. 1998 ; 38 (4). 589-593.
29. Ricci G., Patrizi A., Specchia F., et al. Effect of house dust mite avoidance measures in children with atopic dermatitis. Br J Dermatol. 2000 ; 143 (2). 379-384.
30. Gutgesell C., Heise S., Seubert S., et al. Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. Br J Dermatol. 2001 ; 145 (1). 70-74.
31. Sanda T., Yasue T., Oohashi M., et al. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol. 1992 ; 89 (3). 653-657.
32. Andersen PH, Bindslev-Jensen C., Mosbech H., et al. Skin symptoms in patients with atopic dermatitis using enzyme-containing detergents. A placebo-controlled study. Acta Derm Venereol. 1998 ; 78 (1). 60-62.
33. Vender RB Alternative treatment for Atopic Dermatitis: a selective review. Skin Therapy Lett. 2002 ; 7 (2). 1-4.
34. Sheehan MP, Rustin MH, Atherton DJ, et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet. 1992 ; 340 (8810). 13-17.
35. Giordano-Labadie F., Schwarze HP, Bazex J. Allergic contact dermatitis from camomile used in phytotherapy. Contact Dermatitis. 2000 ; 42 (4). 247. (Pubitemid 30162607)
36. Higaki S., Morimatsu S., Morohashi M., et al. Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations. J Int Med Res. 1997 ; 25 (6). 318-324.
37. www.nice.org.uk (accessed October 25, 2009 ).
38. Hanifin JM, Chan SC, Cheng JB, et al. Type 4 phosphodiesterase inhibitors have clinical and In vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol. 1996 ; 107 (1). 51-56.
39. Ramos C. CE Lecture on Atopic Dermatitis.
40. Gimenez JC Atopic dermatits a review article. Alergol Immunol Clin. 2000 ; 15 (1). 279-295.
41. Bleehen SS, Chu AC, Hamann I., et al. Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment andonce-daily vehicle cream application versus twice-daily treatment. Br J Dermatol. 1995 ; 133 (4). 592-597.
42. Sears HW, Bailey JW, Yeadon A. Efficacy and safety of hydrocortisone buteprate 0.1% cream in patients with atopic dermatitis. Clin Ther. 1997 ; 19 (4). 710-719.
43. www.primewest.org (Accessed October 28, 2009 ).
44. Ashcroft DM, Dimmock P., Garside R., et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of Atopic Dermatitis: meta-analysis of randomized controlled trials. BMJ. 2005 ; 7 (8). 330-516.
45. Weinberg JM Formulary review of therapeutic alternatives for atopic dermatitis: focus on pimecrolimus. J Manag Care Pharm. 2005 ; 11 (1). 56-64.
46. Paul C., Cork M., Rossi AB, et al. Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years. Pediatrics. 2006 ; 117 (1). e118 - e128.
47. Berger TG, Duvic M., Van Voorhees AS, et al. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol. 2006 ; 54 (5). 818-823.
48. Fonacier L., Spergel J., Charlesworth EN, et al. Report of the topical calcineurin inhibitor task force of the American College of allergy, asthma and immunology and the american academy of allergy, asthma and immunology. J Allergy Clin Immunol. 2005 ; 115 (6). 1249-1253.
49. Abramowicz M., et al. Drugs for allergic disorders. Treatment Guidelines. Med Lett. 2007 ; 5 (60). 71-80.